SIGNIFICANCE OF SPECIFIC EPSTEIN-BARR-VIRUS IGA AND ELEVATED IGG ANTIBODIES TO VIRAL CAPSID ANTIGENS IN NASOPHARYNGEAL CARCINOMA PATIENTS

被引:35
作者
HADAR, T
RAHIMA, M
KAHAN, E
SIDI, J
RAKOWSKY, E
SAROV, B
SAROV, I
机构
[1] TEL AVIV UNIV,SCH MED,IL-69978 TEL AVIV,ISRAEL
[2] SOROKA UNIV HOSP,EPIDEMIOL UNIT,BEERSHEBA,ISRAEL
[3] SOROKA UNIV HOSP,VIROL UNIT,BEERSHEBA,ISRAEL
[4] BEN GURION UNIV NEGEV,FAC SCI,IL-84105 BEERSHEBA,ISRAEL
[5] BEILINSON MED CTR,DEPT OTOLARYNGOL & HEAD & NECK SURG,IL-49100 PETACH TIKVA,ISRAEL
[6] BEILINSON MED CTR,DEPT ONCOL,IL-49100 PETACH TIKVA,ISRAEL
[7] BEILINSON MED CTR,EPIDEMIOL & EVALUAT UNIT,IL-49100 PETACH TIKVA,ISRAEL
关键词
D O I
10.1002/jmv.1890200405
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
引用
收藏
页码:329 / 339
页数:11
相关论文
共 35 条
[11]  
HENLE W, 1973, JNCI-J NATL CANCER I, V51, P361
[12]  
Ho J H, 1972, Adv Cancer Res, V15, P57, DOI 10.1016/S0065-230X(08)60372-3
[13]   DIRECT EVIDENCE FOR PRESENCE OF EPSTEIN-BARR VIRUS DNA AND NUCLEAR ANTIGEN IN MALIGNANT EPITHELIAL-CELLS FROM PATIENTS WITH POORLY DIFFERENTIATED CARCINOMA OF NASOPHARYNX [J].
KLEIN, G ;
GIOVANELLA, BC ;
LINDAHL, T ;
FIALKOW, PJ ;
SINGH, S ;
STEHLIN, JS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1974, 71 (12) :4737-4741
[14]  
LANIER A, 1980, CANCER-AM CANCER SOC, V46, P2100, DOI 10.1002/1097-0142(19801101)46:9<2100::AID-CNCR2820460932>3.0.CO
[15]  
2-G
[16]   LONG-TERM FOLLOW-UP OF IGG AND IGA ANTIBODIES AGAINST VIRAL CAPSID ANTIGENS OF EPSTEIN-BARR VIRUS IN NASOPHARYNGEAL CARCINOMA [J].
LYNN, TC ;
TU, SM ;
KAWAMURA, A .
JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1985, 99 (06) :567-572
[17]  
LYNN TC, 1977, ARCH OTOLARYNGOL, V103, P128
[18]  
MAUSNER JS, 1974, EPIDEMIOLOGY INTRO T, P242
[19]  
MILLER D, 1971, ARCHIV OTOLARYNGOL, V94, P104
[20]   ANTIBODIES TO EPSTEIN-BARR VIRUS IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA AND IN COMPARISON GROUPS [J].
NEEL, HB ;
PEARSON, GR ;
TAYLOR, WF .
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1984, 93 (05) :477-482